Global Oncology Molecular Diagnostics Market Size, Status and Forecast 2019-2025
Molecular diagnostics is one of the most transformative and dynamic areas of diagnostics. It is a technique used for analyzing biological markers in proteome and genome. Molecular diagnostics tests are increasingly used in oncology, infectious disease, pharmacogenomics, and human leukocyte antigen typing.
Oncology molecular diagnostics is a major application of molecular biology and is increasingly used for cancer screening, therapy selection, diagnosis, and relapse monitoring. Some of the major that are diagnosed and treated by molecular diagnostics are breast, ovarian, cervical, head and neck, pancreatic, colorectal, brain, prostate, lung, and endometrial cancers.
In 2018, the global Oncology Molecular Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Oncology Molecular Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oncology Molecular Diagnostics development in United States, Europe and China.
The key players covered in this study
Abbott Laboratories
Bayer Healthcare
Beckton Dickinson
Cepheid
Dako
Danaher
Gen Probe
Qiagen
Roche Diagnostics
Siemens
Sysmex
Market segment by Type, the product can be split into
PCR
INAAT
DNA sequencing & NGS
In situ hybridization
DNA microarrays
Other
Market segment by Application, split into
Infectious diseases
oncology
Genetic tests
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Oncology Molecular Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Oncology Molecular Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Oncology Molecular Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Oncology molecular diagnostics is a major application of molecular biology and is increasingly used for cancer screening, therapy selection, diagnosis, and relapse monitoring. Some of the major that are diagnosed and treated by molecular diagnostics are breast, ovarian, cervical, head and neck, pancreatic, colorectal, brain, prostate, lung, and endometrial cancers.
In 2018, the global Oncology Molecular Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Oncology Molecular Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oncology Molecular Diagnostics development in United States, Europe and China.
The key players covered in this study
Abbott Laboratories
Bayer Healthcare
Beckton Dickinson
Cepheid
Dako
Danaher
Gen Probe
Qiagen
Roche Diagnostics
Siemens
Sysmex
Market segment by Type, the product can be split into
PCR
INAAT
DNA sequencing & NGS
In situ hybridization
DNA microarrays
Other
Market segment by Application, split into
Infectious diseases
oncology
Genetic tests
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Oncology Molecular Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Oncology Molecular Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Oncology Molecular Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
